SciClone COO Steps Down

Friedhelm Blobel, the company's president and CEO, will take on the COO duties.
Author:
Publish date:

The chief operating officer of drug developer

SciClone Pharmaceuticals

(SCLN)

has stepped down from his post, the company announced Monday.

Alfred Rudolph, who joined the company in 1997, left last Friday. Friedhelm Blobel, the company's president and CEO, will take on the COO duties.

Shares of SciClone lost 2.1% to $2.74.